Weichang Zhou
Director/Board Member presso WUXI BIOLOGICS (CAYMAN) INC.
Patrimonio netto: 451 558 $ in data 31/03/2024
Profilo
Attualmente, Weichang Zhou occupa la posizione di direttore esecutivo, Chief Technology Officer & EVP presso Wuxi Biologics (Cayman), Inc. In precedenza ha occupato la posizione di direttore associato presso Merck & Co., Inc. Il dott. Zhou ha conseguito una laurea presso la Jiangxi University of Science & Technology e un dottorato presso l'Università di Hannover.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
27/03/2024 | 247 139 ( 0.01% ) | 451 558 $ | 31/03/2024 |
Posizioni attive di Weichang Zhou
Società | Posizione | Inizio |
---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01/05/2016 |
WUXI XDC CAYMAN INC. | Director/Board Member | 01/12/2020 |
Precedenti posizioni note di Weichang Zhou
Società | Posizione | Fine |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2012 |
PDL BIOPHARMA, INC. | Director/Board Member | 01/02/2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/10/2002 |
Formazione di Weichang Zhou
University of Hannover | Doctorate Degree |
Jiangxi University of Science & Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Aziende private | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Borsa valori
- Insiders
- Weichang Zhou